No matter how cynical the overall market is, Guardant Health Inc (GH) performance over the last week is recorded -3.36%

Guardant Health Inc (NASDAQ: GH) kicked off on Tuesday, down -0.67% from the previous trading day, before settling in for the closing price of $40.24. Over the past 52 weeks, GH has traded in a range of $20.14-$52.92.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Healthcare Sector giant saw their annual sales surged by 28.17% over the last five years. While this was happening, its average annual earnings per share was recorded 22.03%. With a float of $117.61 million, this company’s outstanding shares have now reached $123.65 million.

The firm has a total of 2021 workers. Let’s measure their productivity. In terms of profitability, gross margin is 61.34%, operating margin of -58.78%, and the pretax margin is -53.67%.

Guardant Health Inc (GH) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Guardant Health Inc is 5.07%, while institutional ownership is 96.27%. The most recent insider transaction that took place on May 19 ’25, was worth 4,645. In this transaction Director of this company sold 116 shares at a rate of $40.04, taking the stock ownership to the 3,479 shares. Before that another transaction happened on May 19 ’25, when Company’s Director proposed sale 116 for $40.04, making the entire transaction worth $4,645.

Guardant Health Inc (GH) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 22.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.66% during the next five years compared to -33.61% drop over the previous five years of trading.

Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators

Take a look at Guardant Health Inc’s (GH) current performance indicators. Last quarter, stock had a quick ratio of 3.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.40.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -2.39 in one year’s time.

Technical Analysis of Guardant Health Inc (GH)

Analysing the last 5-days average volume posted by the [Guardant Health Inc, GH], we can find that recorded value of 1.46 million was lower than the volume posted last year of 2.36 million. As of the previous 9 days, the stock’s Stochastic %D was 27.04%. Additionally, its Average True Range was 2.42.

During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 43.72%, which indicates a significant increase from 7.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.52% in the past 14 days, which was lower than the 71.28% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $43.69, while its 200-day Moving Average is $35.01. Now, the first resistance to watch is $40.41. This is followed by the second major resistance level at $40.85. The third major resistance level sits at $41.35. If the price goes on to break the first support level at $39.46, it is likely to go to the next support level at $38.96. Now, if the price goes above the second support level, the third support stands at $38.52.

Guardant Health Inc (NASDAQ: GH) Key Stats

The company with the Market Capitalisation of 4.95 billion has total of 123,888K Shares Outstanding. Its annual sales at the moment are 739,020 K in contrast with the sum of -436,370 K annual income. Company’s last quarter sales were recorded 203,470 K and last quarter income was -95,160 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.